KeyBanc raised the firm’s price target on American Healthcare REIT (AHR) to $43 from $40 to reflect the increase to the firm’s estimates, an improving cost of capital, below-average leverage, and a favorable fundamental backdrop for senior housing fundamentals. KeyBanc keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT initiated with a Buy at UBS
- Buy Rating for American Healthcare REIT, Inc. Driven by Strong AFFO Growth and Strategic Expansion in Senior Housing
- American Healthcare REIT Announces Quarterly Distribution
- American Healthcare REIT price target raised to $48 from $45 at Morgan Stanley
- American Healthcare REIT price target raised to $47 from $42 at Scotiabank